Sign in →

Test Code MEVI Methemoglobinemia Interpretation

Useful For

Interpretation of the methemoglobinemia evaluation results

 

Diagnosis of methemoglobinemia and sulfhemoglobinemia and possible hereditary (congenital) causes

 

Differentiation of methemoglobinemia and sulfhemoglobinemia from other causes of cyanosis (eg, congenital heart disease)

Method Name

Only orderable as part of a profile. For more information see MEV1 / Methemoglobinemia Evaluation.

 

Medical Interpretation

Reporting Name

Methemoglobinemia Interpretation

Specimen Type

Whole Blood EDTA

Specimen Stability Information

Specimen Type Temperature Time Special Container
Whole Blood EDTA Refrigerated 72 hours

Clinical Information

Methemoglobin:

Methemoglobin forms when the hemoglobin molecule iron is in the ferric (Fe[3+]) form instead of the functional ferrous (Fe[2+]) form. Methemoglobinemia can be hereditary or acquired and is present by definition when methemoglobin levels are greater than the normal range. Acquired methemoglobinemia results after toxic exposure to nitrates and nitrites/nitrates (fertilizer, nitric oxide), topical anesthetics (“caines"), dapsone, naphthalene (moth balls/toilet deodorant cakes), and industrial use of aromatic compounds (aniline dyes).

 

Congenital methemoglobinemias are rare. They are due either to:

-A deficiency of cytochrome b5 reductase (methemoglobin reductase) in erythrocytes, an autosomal recessive disorder resulting from genetic variants in either CYB5R3 or CYB5A genes.(1,2) Type IV is thought to be extraordinarily rare. Type III is no longer a category.

 

-One of several intrinsic structural disorders of hemoglobin, called M-hemoglobins (M-Hb), all of which are inherited in an autosomal dominant manner.(3,4) Classically, M-Hb result from histidine-to-tyrosine substitutions at the proximal or distal histidine important in coordinating the oxygen molecule. These include alpha-, beta- and gamma-chain variants. Rarely, other substitutions outside the proximal and distal histidine location can cause hemoglobin variants that increase methemoglobin or sulfhemoglobin levels. Most M-Hb variants are readily identified by high-performance liquid chromatography (HPLC) or mass spectrometry methods with characteristic electrophoresis patterns; however, some require more specialized techniques. Most are associated with increased methemoglobin, with or without an increase in sulfhemoglobin. Alpha chain M-Hb variants can be associated with increased sulfhemoglobin without an increase in methemoglobin.

 

Sulfhemoglobin:

Sulfhemoglobin cannot combine with oxygen. When acquired, sulfhemoglobinemia can be associated with cyanosis and often accompanies methemoglobinemia. Sulfhemoglobinemia has been associated with exposure to sumatriptan, sulfonamides, metoclopramide, paint or varnish vapors, dimethyl sulfoxide (DMSO), acetanilide, phenacetin, trinitroluene, zinc ethylene bisdithiocarbamate (a fungicide), and flutamide. It is important to note that some hemoglobin variants are known to interfere with this test (especially M-Hb), and sulfhemoglobin absorbance can be increased due to the hemoglobin variant. Hemoglobin evaluation that includes the HPLC method is recommended to exclude this possibility.

 

In contrast to methemoglobinemia, sulfhemoglobinemia persists until the erythrocytes containing it are destroyed. Therefore, blood level of sulfhemoglobin declines gradually over a period of weeks.

Reference Values

Only orderable as part of a profile. For more information see MEV1 / Methemoglobinemia Evaluation.

 

Definitive results and an interpretive report will be provided.

Interpretation

This is a consultative evaluation in which the history and previous laboratory values are reviewed by a hematologist who is an expert on these disorders. Appropriate tests are performed and an interpretive report is issued.

Cautions

Sulfhemoglobin is exceedingly stable and does not change in stored or shipped specimens.

 

Methemoglobin is unstable and can degrade at a rate of about 40% per 24 hours.

 

A normal methemoglobin value obtained with stored or shipped specimens does not exclude prior methemoglobinemia of minimal degree. However, significant methemoglobinemia will still be demonstrable.

Method Description

A hematopathologist who is an expert in these disorders evaluates the case and an interpretive report is issued.

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

Not Applicable

CPT Code Information

83020-26

LOINC Code Information

Test ID Test Order Name Order LOINC Value
MEVI Methemoglobinemia Interpretation In Process

 

Result ID Test Result Name Result LOINC Value
608086 Methemoglobinemia Interpretation 59465-5
608108 Reviewed By 18771-6

Day(s) Performed

Monday through Friday

Report Available

3 to 25 days